These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24225259)

  • 1. Comparative study of novel ultradeformable liposomes: menthosomes, transfersomes and liposomes for enhancing skin permeation of meloxicam.
    Duangjit S; Obata Y; Sano H; Onuki Y; Opanasopit P; Ngawhirunpat T; Miyoshi T; Kato S; Takayama K
    Biol Pharm Bull; 2014; 37(2):239-47. PubMed ID: 24225259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menthosomes, novel ultradeformable vesicles for transdermal drug delivery: optimization and characterization.
    Duangjit S; Obata Y; Sano H; Kikuchi S; Onuki Y; Opanasopit P; Ngawhirunpat T; Maitani Y; Takayama K
    Biol Pharm Bull; 2012; 35(10):1720-8. PubMed ID: 23037161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers.
    Duangjit S; Opanasopit P; Rojanarata T; Ngawhirunpat T
    AAPS PharmSciTech; 2013 Mar; 14(1):133-40. PubMed ID: 23242556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elastic liposomes bearing meloxicam-beta-cyclodextrin for transdermal delivery.
    Jain SK; Gupta Y; Jain A; Amin S
    Curr Drug Deliv; 2008 Jul; 5(3):207-14. PubMed ID: 18673264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes.
    Duangjit S; Pamornpathomkul B; Opanasopit P; Rojanarata T; Obata Y; Takayama K; Ngawhirunpat T
    Int J Nanomedicine; 2014; 9():2005-17. PubMed ID: 24851047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery.
    El-Menshawe SF; Hussein AK
    Pharm Dev Technol; 2013; 18(4):779-86. PubMed ID: 21913880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deformable Liposomal Hydrogel for Dermal and Transdermal Delivery of Meloxicam.
    Zhang ZJ; OsmaƂek T; Michniak-Kohn B
    Int J Nanomedicine; 2020; 15():9319-9335. PubMed ID: 33262590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of meloxicam/ethanolamine salt formation on percutaneous absorption of meloxicam.
    Ki HM; Choi HK
    Arch Pharm Res; 2007 Feb; 30(2):215-21. PubMed ID: 17366744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
    Ah YC; Choi JK; Choi YK; Ki HM; Bae JH
    Int J Pharm; 2010 Jan; 385(1-2):12-9. PubMed ID: 19833177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam.
    Khurana S; Bedi PM; Jain NK
    Chem Phys Lipids; 2013; 175-176():65-72. PubMed ID: 23994283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Mar; 92(6-7):383-92. PubMed ID: 23353874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavosomes, novel deformable liposomes for the co-delivery of anti-inflammatory compounds to skin.
    Zhang ZJ; Michniak-Kohn B
    Int J Pharm; 2020 Jul; 585():119500. PubMed ID: 32512226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30.
    El-Badry M; Fathy M
    Drug Dev Ind Pharm; 2006 Feb; 32(2):141-50. PubMed ID: 16537195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam.
    Jiang Q; Wang J; Ma P; Liu C; Sun M; Sun Y; He Z
    Drug Deliv Transl Res; 2018 Feb; 8(1):64-72. PubMed ID: 29181834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation, optimization and evaluation of ibuprofen loaded menthosomes for transdermal delivery.
    Nayak D; Shetty MM; Halagali P; Rathnanand M; Gopinathan A; John J; Krishna Tippavajhala V
    Int J Pharm; 2024 Nov; 665():124671. PubMed ID: 39245088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for meloxicam delivery to and across the skin: a review.
    Chen J; Gao Y
    Drug Deliv; 2016 Oct; 23(8):3146-3156. PubMed ID: 26956920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Percutaneous absorption of meloxicam patches in hairless mouse].
    Gao QZ; Yang LY; Ding PT; He ZG
    Yao Xue Xue Bao; 2007 Dec; 42(12):1320-2. PubMed ID: 18338648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of ion-pairing and chemical enhancers on the transdermal delivery of meloxicam.
    Zhang JY; Fang L; Tan Z; Wu J; He ZG
    Drug Dev Ind Pharm; 2009 Jun; 35(6):663-70. PubMed ID: 19259875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam.
    Khalil RM; Abd-Elbary A; Kassem MA; Ghorab MM; Basha M
    Pharm Dev Technol; 2014 May; 19(3):304-14. PubMed ID: 23528038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.